CX3CL1 Induces Vertebral Microvascular Barrier Dysfunction via the Src/P115-RhoGEF/ROCK Signaling Pathway.

Front Cell Neurosci · 2020 · PMC7193116 · PMID 32390803

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

We incubated VMECs with various concentrations of CX3CL1 (0, 0.1, and 1 μg/ml) for 6 h and found that the P-MLC expression exhibited an increasing trend with increasing concentrations of CX3CL1 ( Figures 3A,B ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.